Namsos Anaesthesia Children Outcome Study
Launched by HELSE NORD-TRØNDELAG HF · Feb 29, 2020
Trial Information
Current as of April 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adenotomy and/or tonsillotomy and/or tonsillectomy
- • ASA physical status class I or II
- Exclusion Criteria:
- • unexperienced ear-nose-throat (ENT) surgeon (ENT surgeon \< 1 year of training, ENT surgeon without experience with the use of laryngeal mask as airway during adenotomy/tonsillotomy/tonsillectomy)
- • preoperative syndromes
- • ASA physical status class \> 2
- • missing written consent from parents/guardians
About Helse Nord Trøndelag Hf
Helse Nord-Trøndelag HF is a prominent healthcare provider in Norway, dedicated to delivering high-quality medical services and advancing clinical research. As a regional health enterprise, it plays a pivotal role in the integration of health services, focusing on patient-centered care, innovation, and collaboration with academic institutions. The organization is committed to enhancing health outcomes through rigorous clinical trials, contributing to the development of new therapies and improving treatment protocols. With a strong emphasis on ethical standards and scientific integrity, Helse Nord-Trøndelag HF is at the forefront of fostering a robust research environment that benefits both patients and the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Namsos, Trøndelag, Norway
Trondheim, Trøndelag, Norway
Patients applied
Trial Officials
Hallvard Græslie, MD
Study Chair
Head of surgical Clinic, Namsos Hospital, Nord-Trondelag Hospital Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials